Your browser doesn't support javascript.
loading
Pathophysiology, Clinical Manifestations, and Treatment of Lichen Sclerosus: A Systematic Review.
Fergus, Kirkpatrick B; Lee, Austin W; Baradaran, Nima; Cohen, Andrew J; Stohr, Bradley A; Erickson, Bradley A; Mmonu, Nnenaya A; Breyer, Benjamin N.
Afiliación
  • Fergus KB; Department of Urology, University of California, San Francisco, San Francisco, CA.
  • Lee AW; Department of Urology, University of California, San Francisco, San Francisco, CA.
  • Baradaran N; Department of Urology, University of California, San Francisco, San Francisco, CA.
  • Cohen AJ; Department of Urology, University of California, San Francisco, San Francisco, CA.
  • Stohr BA; Department of Pathology, University of California, San Francisco, San Francisco, CA.
  • Erickson BA; Department of Urology, University of Iowa, Iowa City, IA.
  • Mmonu NA; Department of Urology, University of California, San Francisco, San Francisco, CA.
  • Breyer BN; Department of Urology, University of California, San Francisco, San Francisco, CA; Department of Biostatistics and Epidemiology, University of California, San Francisco, San Francisco, CA. Electronic address: Benjamin.Breyer@ucsf.edu.
Urology ; 135: 11-19, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31605681
ABSTRACT

OBJECTIVE:

To elucidate current understanding on the pathophysiological mechanism of genital lichen sclerosus (LS), urologic manifestations, and treatment options. MATERIALS AND

METHODS:

The Medline/PubMed and Embase databases were systematically reviewed for publications pertaining to LS. After applying inclusion and exclusion criteria, references were assessed for relevance to the pathophysiology, presentation, and treatment of LS by title and abstract review by 2 independent reviewers, yielding 186 articles for assessment.

RESULTS:

The contemporary understanding of the epidemiology and histology of LS is reviewed herein. Additionally, we explore in detail the 3 hypotheses regarding the pathophysiological mechanism contributing to disease presentation infectious etiology, primary immune dysregulation, and the isotraumatopic response. We summarize the available biological evidence supporting each hypothesis. This discussion provides context for understanding LS morbidity and may spur new avenues of research. For the clinician, we review the clinical presentation of disease, including the risk of progression to squamous cell carcinoma. The current medical and surgical treatment options are also detailed.

CONCLUSION:

LS remains a potentially insidious disease which may lead to debilitating urinary and sexual dysfunction. Cross disciplinary research should aim for earlier detection, as well as more effective and durable treatment. The exact cause of LS remains unknown.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Liquen Escleroso y Atrófico / Balanitis Xerótica Obliterante / Liquen Escleroso Vulvar Tipo de estudio: Diagnostic_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Male Idioma: En Revista: Urology Año: 2020 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Liquen Escleroso y Atrófico / Balanitis Xerótica Obliterante / Liquen Escleroso Vulvar Tipo de estudio: Diagnostic_studies / Prevalence_studies / Risk_factors_studies / Systematic_reviews Límite: Female / Humans / Male Idioma: En Revista: Urology Año: 2020 Tipo del documento: Article País de afiliación: Canadá